Hypoxia-induced pulmonary hypertension in an optimized environment for the guineapig

被引:6
|
作者
Bochnowicz, S [1 ]
Osborn, RR [1 ]
Hay, DWP [1 ]
Underwood, DC [1 ]
机构
[1] SmithKline Beecham Pharmaceut, Dept Pulm Pharmacol, King Of Prussia, PA 19406 USA
关键词
pulmonary hypertension; hypoxia; hypertrophy; hyperplasia; guineapig;
D O I
10.1258/002367797780596112
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Prolonged exposure to hypoxia elicits a variety of time-related morphologic and physiologic changes in the pulmonary vasculature of mammals, including humans. The study of hypoxia induced changes in rodents generally requires a prolonged-exposure to 9% oxygen for a minimum of 10 days in an airtight chamber, which has only been generally described in the literature as large (200-400 l), sealed acrylic chambers. To assist in the search for better therapies for diseases associated with chronic hypoxia using animal models, we have custom-built an airtight chamber for hypoxic exposure of rodents, and characterized the effect of chronic hypoxia on functional and morphologic changes in the pulmonary vasculature of the guineapig using this system. This chamber has been designed to alleviate any unnecessary stress related to food or water intake, cleanliness and-excess illumination to the animals during the hypoxic-exposure period. Chronic exposure of the guineapig to hypoxia (0-21 days). produced time-related physiologic, morphologic, and haematologic changes. For example, after 10 days in hypoxia (9% oxygen), pulmonary artery pressure was significantly increased from 13 +/- 1 mmHg in normoxic controls (day 0, n=6) to 26 +/- 0 mmHg (day 10, n=4, P < 0.01). Right ventricular hypertrophy in hypoxic animals, presented as a ratio of right ventricle free wall weight to body weight, showed a significant increase from 0.054 +/- 0.004 (day 0) to 0.069 +/- 0.004 on day 10 (P < 0.05), while age-matched normoxic animals showed no changes in right ventricular weight (day 0=0.059; day 10=0.058; P>0.05). Red blood cell count significantly increased over the same time period, from 5.9 +/- 0.1 (day 0) to 6.4 +/- 0.1 (day 10; P < 0.05), as did haematocrit, 48 +/- 0.7 (day 0) to 61 +/- 0.9 (day 10, P < 0.05), and haemoglobin, 16 +/- 0.2 (day 0) to 20 +/- 0.1 (day 10, P < 0.05). It is concluded that considerations-for the wellbeing of the test animals (i.e. continuous water, ample food supplies, burrow-like hiding places, sanitation and protection from excess illumination) can easily be incorporated into a hypoxic chamber. The purpose of the present study was to explore modifications that may provide the animal with an optimized environment which will reduce anxiety and stress, as seen in their behaviour when inside the chambers, and to thoroughly characterize the morphologic and physiologic changes associated with chronic hypoxia which develop in a consistent time-related manner.
引用
收藏
页码:347 / 356
页数:10
相关论文
共 50 条
  • [1] Sildenafil inhibits hypoxia-induced pulmonary hypertension
    Zhao, L
    Mason, NA
    Morrell, NW
    Kojonazarov, B
    Sadykov, A
    Maripov, A
    Mirrakhimov, MM
    Aldashev, A
    Wilkins, MR
    CIRCULATION, 2001, 104 (04) : 424 - 428
  • [2] Oxidative stress and hypoxia-induced pulmonary hypertension
    Alan Keegan
    Respiratory Research, 2 (1)
  • [3] High relative humidity environment alleviates hypoxia-induced pulmonary arterial hypertension in mice
    Song, Jiaoyan
    Cheng, Jiangtao
    Ju, Wenhao
    Hu, Dan
    Zhuang, Donglin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 733
  • [4] Dipyridamole attenuates hypoxia-induced pulmonary hypertension.
    Ziegler, JW
    Ivy, DD
    Kinsella, JP
    Wiggins, JW
    Abman, SH
    PEDIATRIC RESEARCH, 1996, 39 (04) : 227 - 227
  • [5] The emerging role of microRNAs in hypoxia-induced pulmonary hypertension
    Mohsenin, Vahid
    SLEEP AND BREATHING, 2016, 20 (03) : 1059 - 1067
  • [6] Role of Interstitial Macrophages in Hypoxia-Induced Pulmonary Hypertension
    Kumar, R.
    Mickael, C.
    Kassa, B.
    Sanders, L.
    Kumar, S.
    Janssen, W. J.
    Stenmark, K. R.
    Tuder, R. M.
    Graham, B. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [7] The emerging role of microRNAs in hypoxia-induced pulmonary hypertension
    Vahid Mohsenin
    Sleep and Breathing, 2016, 20 : 1059 - 1067
  • [8] Tipifarnib prevents development of hypoxia-induced pulmonary hypertension
    Duluc, Lucie
    Ahmetaj-Shala, Blerina
    Mitchell, Jane
    Abdul-Salam, Vahitha B.
    Mahomed, Abdul S.
    Aldabbous, Lulwah
    Oliver, Eduardo
    Iannone, Lucio
    Dubois, Olivier D.
    Storck, Elisabeth M.
    Tate, Edward W.
    Zhao, Lan
    Wilkins, Martin R.
    Wojciak-Stothard, Beata
    CARDIOVASCULAR RESEARCH, 2017, 113 (03) : 276 - 287
  • [9] Involvement of Microglial Cells in Hypoxia-induced Pulmonary Hypertension
    Oliveira, Aline C.
    Sharma, Ravindra K.
    Aquino, Victor
    Lobaton, Gilberto
    Bryant, Andrew J.
    Harrison, Jeffrey K.
    Richards, Elaine M.
    Raizada, Mohan K.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2018, 59 (02) : 271 - 273
  • [10] EETs exacerbate chronic hypoxia-induced pulmonary hypertension
    Kandhi, Sharath
    Alruwaili, Norah
    Froogh, Ghezal
    Yang, Yang-Ming
    Deng, Wensheng
    Wolin, Michael S.
    Huang, An
    Sun, Dong
    FASEB JOURNAL, 2018, 32 (01):